DK0920426T3 - Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning - Google Patents

Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning

Info

Publication number
DK0920426T3
DK0920426T3 DK97940080T DK97940080T DK0920426T3 DK 0920426 T3 DK0920426 T3 DK 0920426T3 DK 97940080 T DK97940080 T DK 97940080T DK 97940080 T DK97940080 T DK 97940080T DK 0920426 T3 DK0920426 T3 DK 0920426T3
Authority
DK
Denmark
Prior art keywords
inhibitory effect
thiazole derivatives
pct
phosphodiesterase inhibitory
novel thiazole
Prior art date
Application number
DK97940080T
Other languages
English (en)
Inventor
Hermann Amschler
Thomas Martin
Beate Schmidt
Hildegard Boss
Thomas Baer
Wolf-Ruediger Ulrich
Dietrich Haefner
Dieter Flockerzi
Ulrich Thibaut
Armin Hatzelmann
Hans-Peter Kley
Rolf Beume
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0920426T3 publication Critical patent/DK0920426T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK97940080T 1996-08-26 1997-08-13 Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning DK0920426T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19634411 1996-08-26
EP96113737 1996-08-28
PCT/EP1997/004435 WO1998008841A1 (de) 1996-08-26 1997-08-13 Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung

Publications (1)

Publication Number Publication Date
DK0920426T3 true DK0920426T3 (da) 2004-02-02

Family

ID=26028746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97940080T DK0920426T3 (da) 1996-08-26 1997-08-13 Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning

Country Status (12)

Country Link
US (1) US6011037A (da)
EP (1) EP0920426B9 (da)
JP (1) JP2000516940A (da)
AT (1) ATE251153T1 (da)
AU (1) AU4205197A (da)
CY (1) CY2509B1 (da)
DE (1) DE59710816D1 (da)
DK (1) DK0920426T3 (da)
ES (1) ES2208950T3 (da)
PT (1) PT920426E (da)
SI (1) SI0920426T1 (da)
WO (1) WO1998008841A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212089B1 (en) 1999-08-21 2006-03-22 ALTANA Pharma AG Synergistic combination of roflumilast and salmeterol
IL160327A0 (en) 2001-08-13 2004-07-25 Janssen Pharmaceutica Nv 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1991212A1 (en) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (en) * 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2707357B1 (en) 2011-05-10 2017-01-18 Merck Sharp & Dohme Corp. Pyridyl aminopyridines as syk inhibitors
US9145391B2 (en) 2011-05-10 2015-09-29 Merck Sharp & Dohme Corp. Bipyridylaminopyridines as Syk inhibitors
MX2013013090A (es) * 2011-05-10 2013-12-16 Merck Sharp & Dohme Aminopirimidinas como inhibidores de tirosina cinaza del bazo.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934937T3 (da) * 1990-11-30 2002-04-02 Otsuka Pharma Co Ltd Azolderivater som superoxidradikalinhibitor
AU657413C (en) * 1992-05-29 2007-05-03 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives for the release of superoxide radical
GB9315017D0 (en) * 1993-07-20 1993-09-01 Glaxo Lab Sa Chemical compounds
EP0772606A1 (en) * 1994-07-27 1997-05-14 G.D. SEARLE & CO. Substituted thiazoles for the treatment of inflammation

Also Published As

Publication number Publication date
CY2509B1 (en) 2005-12-23
ES2208950T3 (es) 2004-06-16
JP2000516940A (ja) 2000-12-19
DE59710816D1 (de) 2003-11-06
US6011037A (en) 2000-01-04
EP0920426B1 (de) 2003-10-01
SI0920426T1 (en) 2004-04-30
ATE251153T1 (de) 2003-10-15
AU4205197A (en) 1998-03-19
WO1998008841A1 (de) 1998-03-05
PT920426E (pt) 2004-02-27
EP0920426B9 (de) 2005-04-06
EP0920426A1 (de) 1999-06-09

Similar Documents

Publication Publication Date Title
DK0920426T3 (da) Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning
ATE233247T1 (de) Phtalazinonen
ATE228507T1 (de) Substituierte 6-phenylphenanthridine
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
DK1042319T3 (da) Dihydrobenzofuraner
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
DK1003724T3 (da) Substituerede quinolin-derivater med antiviral virkning
TW282458B (da)
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.